Sharon M. Kelly

15.9k total citations · 3 hit papers
234 papers, 12.5k citations indexed

About

Sharon M. Kelly is a scholar working on Molecular Biology, Epidemiology and Materials Chemistry. According to data from OpenAlex, Sharon M. Kelly has authored 234 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Molecular Biology, 53 papers in Epidemiology and 43 papers in Materials Chemistry. Recurrent topics in Sharon M. Kelly's work include Substance Abuse Treatment and Outcomes (42 papers), Enzyme Structure and Function (41 papers) and Opioid Use Disorder Treatment (37 papers). Sharon M. Kelly is often cited by papers focused on Substance Abuse Treatment and Outcomes (42 papers), Enzyme Structure and Function (41 papers) and Opioid Use Disorder Treatment (37 papers). Sharon M. Kelly collaborates with scholars based in United Kingdom, United States and Germany. Sharon M. Kelly's co-authors include Nicholas C. Price, Thomas J. Jess, Nicholas C. Price, Robert P. Schwartz, Kevin E. O’Grady, Shannon Gwin Mitchell, Barry S. Brown, E. Hendry, Malcolm Kadodwala and Nikolaj Gadegaard and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Sharon M. Kelly

228 papers receiving 12.3k citations

Hit Papers

How to study proteins by ... 2000 2026 2008 2017 2005 2010 2000 500 1000 1.5k 2.0k 2.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon M. Kelly United Kingdom 49 6.3k 1.7k 1.4k 1.4k 1.2k 234 12.5k
Matthew A. Cooper Australia 68 11.9k 1.9× 2.5k 1.5× 879 0.6× 763 0.6× 2.3k 2.0× 364 23.5k
Edward N. Baker New Zealand 68 10.7k 1.7× 908 0.5× 1.1k 0.8× 3.1k 2.3× 500 0.4× 365 18.2k
David J. Meyer United States 52 4.9k 0.8× 494 0.3× 703 0.5× 800 0.6× 623 0.5× 225 9.6k
Takashi Suzuki Japan 59 3.9k 0.6× 4.1k 2.5× 551 0.4× 826 0.6× 328 0.3× 527 12.5k
Kazuyoshi Takeda Japan 77 6.1k 1.0× 1.4k 0.8× 371 0.3× 585 0.4× 535 0.5× 625 25.0k
Daniel Raftery United States 65 8.3k 1.3× 1.2k 0.7× 496 0.4× 1.7k 1.3× 1.5k 1.3× 313 15.8k
Toshio Tanaka Japan 62 4.5k 0.7× 1.6k 0.9× 456 0.3× 1.7k 1.3× 570 0.5× 824 22.4k
Eric Oldfield United States 82 11.4k 1.8× 1.4k 0.9× 1.0k 0.8× 6.1k 4.5× 605 0.5× 435 25.2k
Haiteng Deng China 65 6.8k 1.1× 1.5k 0.9× 212 0.2× 1.8k 1.3× 472 0.4× 322 13.1k
Brian J. Smith Australia 59 6.6k 1.1× 1.1k 0.7× 1.2k 0.9× 866 0.6× 523 0.5× 246 13.9k

Countries citing papers authored by Sharon M. Kelly

Since Specialization
Citations

This map shows the geographic impact of Sharon M. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon M. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon M. Kelly more than expected).

Fields of papers citing papers by Sharon M. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon M. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon M. Kelly. The network helps show where Sharon M. Kelly may publish in the future.

Co-authorship network of co-authors of Sharon M. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon M. Kelly. A scholar is included among the top collaborators of Sharon M. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon M. Kelly. Sharon M. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nordeck, Courtney, Sharon M. Kelly, Robert P. Schwartz, et al.. (2024). Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial. Addiction Science & Clinical Practice. 19(1). 33–33.
2.
Falade‐Nwulia, Oluwaseun, Sharon M. Kelly, Ju Nyeong Park, et al.. (2023). Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes. International Journal of Drug Policy. 121. 104191–104191. 5 indexed citations
3.
Lau, Andy M., Sharon M. Kelly, Kersti Karu, et al.. (2021). Identification of diverse lipid‐binding modes in the groove of zinc α 2 glycoprotein reveals its functional versatility. FEBS Journal. 289(7). 1876–1896. 2 indexed citations
4.
Pages, Benjamin J., Jennette A. Sakoff, Jayne Gilbert, et al.. (2017). Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analogues. Dalton Transactions. 47(7). 2156–2163. 7 indexed citations
5.
Chandler, Redonna K., Matthew S. Finger, David Farabee, et al.. (2016). The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings. Contemporary Clinical Trials. 48. 166–172. 16 indexed citations
6.
Huang, Sheng, Jioji N. Tabudravu, Somayah S. Elsayed, et al.. (2015). Discovery of a Single Monooxygenase that Catalyzes Carbamate Formation and Ring Contraction in the Biosynthesis of the Legonmycins. Angewandte Chemie International Edition. 54(43). 12697–12701. 45 indexed citations
7.
8.
Gryczynski, Jan, Sharon M. Kelly, Shannon Gwin Mitchell, et al.. (2014). Validation and performance of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) among adolescent primary care patients. Addiction. 110(2). 240–247. 70 indexed citations
9.
Mitchell, Shannon Gwin, Jan Gryczynski, Sharon M. Kelly, et al.. (2013). Treatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status. Journal of Drug Issues. 44(1). 69–82. 11 indexed citations
10.
Christie, John M., A.S. Arvai, Katherine J. Baxter, et al.. (2012). Plant UVR8 Photoreceptor Senses UV-B by Tryptophan-Mediated Disruption of Cross-Dimer Salt Bridges. Science. 335(6075). 1492–1496. 350 indexed citations
11.
Kelly, Sharon M., Barry S. Brown, Elizabeth C. Katz, et al.. (2012). A Comparison of Attitudes Toward Opioid Agonist Treatment among Short-Term Buprenorphine Patients. The American Journal of Drug and Alcohol Abuse. 38(3). 233–238. 22 indexed citations
12.
Conigliaro, Paola, Robert A. Benson, Agapitos Patakas, et al.. (2011). Characterization of the anticollagen antibody response in a new model of chronic polyarthritis. Arthritis & Rheumatism. 63(8). 2299–2308. 9 indexed citations
13.
Pereira, Patricia Marques, Sharon M. Kelly, Paul Gellert, & Christopher F. van der Walle. (2008). Interdomain mobility and conformational stability of type III fibronectin domain pairs control surface adsorption, desorption and unfolding. Colloids and Surfaces B Biointerfaces. 64(1). 1–9. 10 indexed citations
14.
Kelly, Sharon M., et al.. (2007). Health visitors are key to child-centred services.. PubMed. 80(8). 16–7. 1 indexed citations
15.
Menheniott, Trevelyan R., et al.. (2004). Igf2: mechanisms of imprinting in the choroid plexus. Genetics Research. 84(2). 119–119. 2 indexed citations
16.
Morrison, John E., Geoffrey A. Lane, Sharon M. Kelly, & Sylvan E. Stool. (1997). The Jehovah's Witness family, transfusions, and pediatric day surgery. International Journal of Pediatric Otorhinolaryngology. 38(3). 197–205. 3 indexed citations
17.
Kelly, Sharon M. & Nicholas C. Price. (1997). The application of circular dichroism to studies of protein folding and unfolding. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1338(2). 161–185. 419 indexed citations
18.
Boxer, David H., et al.. (1995). Purification and Characterization of the Periplasmic Nickel-Binding Protein NikA of Escherichia coli K12. European Journal of Biochemistry. 227(3). 857–865. 55 indexed citations
19.
Kelly, Sharon M., et al.. (1992). The secondary structure of influenza A M2 transmembrane domain A circular dichroism study. FEBS Letters. 311(3). 256–258. 58 indexed citations
20.
Price, Nicholas C., et al.. (1991). The aromatic amino acid content of the bacterial chaperone protein groEL (cpn60) Evidence for the presence of a single tryptophan. FEBS Letters. 292(1-2). 9–12. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026